John T. Curnutte
2015
In 2015, John T. Curnutte earned a total compensation of $2.5M as Executive Vice President, Research and Development at Portola Pharmaceuticals, a 36% increase compared to previous year.
Compensation breakdown
| Bonus | $21,057 |
|---|---|
| Non-Equity Incentive Plan | $168,458 |
| Option Awards | $821,601 |
| Salary | $419,500 |
| Stock Awards | $1,066,675 |
| Other | $41,203 |
| Total | $2,538,494 |
Curnutte received $1.1M in stock awards, accounting for 42% of the total pay in 2015.
Curnutte also received $21.1K in bonus, $168.5K in non-equity incentive plan, $821.6K in option awards, $419.5K in salary and $41.2K in other compensation.
Rankings
In 2015, John T. Curnutte's compensation ranked 3,769th out of 13,638 executives tracked by ExecPay. In other words, Curnutte earned more than 72.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,769 out of 13,638 | 72nd |
Division Manufacturing | 1,372 out of 5,190 | 74th |
Major group Chemicals And Allied Products | 495 out of 1,854 | 73rd |
Industry group Drugs | 396 out of 1,528 | 74th |
Industry Pharmaceutical Preparations | 313 out of 1,182 | 74th |
Source: SEC filing on April 24, 2017.
Curnutte's colleagues
We found three more compensation records of executives who worked with John T. Curnutte at Portola Pharmaceuticals in 2015.